EP3589129A4 - Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés - Google Patents
Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés Download PDFInfo
- Publication number
- EP3589129A4 EP3589129A4 EP18760302.2A EP18760302A EP3589129A4 EP 3589129 A4 EP3589129 A4 EP 3589129A4 EP 18760302 A EP18760302 A EP 18760302A EP 3589129 A4 EP3589129 A4 EP 3589129A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- purified
- compositions
- terpenes
- cannabinoids
- purposefully selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762465688P | 2017-03-01 | 2017-03-01 | |
US201762469415P | 2017-03-09 | 2017-03-09 | |
US201762475153P | 2017-03-22 | 2017-03-22 | |
US201762477990P | 2017-03-28 | 2017-03-28 | |
US201762489360P | 2017-04-24 | 2017-04-24 | |
US201762490465P | 2017-04-26 | 2017-04-26 | |
US201762490567P | 2017-04-26 | 2017-04-26 | |
US201762491175P | 2017-04-27 | 2017-04-27 | |
US201762491160P | 2017-04-27 | 2017-04-27 | |
US201762491980P | 2017-04-28 | 2017-04-28 | |
US201762491899P | 2017-04-28 | 2017-04-28 | |
US201762509651P | 2017-05-22 | 2017-05-22 | |
US201762510229P | 2017-05-23 | 2017-05-23 | |
US201762510660P | 2017-05-24 | 2017-05-24 | |
US201762510672P | 2017-05-24 | 2017-05-24 | |
US201762511218P | 2017-05-25 | 2017-05-25 | |
US15/616,874 US20170266153A1 (en) | 2015-02-27 | 2017-06-07 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
PCT/US2018/020440 WO2018160827A1 (fr) | 2017-03-01 | 2018-03-01 | Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3589129A1 EP3589129A1 (fr) | 2020-01-08 |
EP3589129A4 true EP3589129A4 (fr) | 2020-11-25 |
Family
ID=63370542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18760302.2A Withdrawn EP3589129A4 (fr) | 2017-03-01 | 2018-03-01 | Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3589129A4 (fr) |
CN (1) | CN110582206A (fr) |
AU (1) | AU2018227544A1 (fr) |
BR (1) | BR112019018088A2 (fr) |
CA (1) | CA3054690A1 (fr) |
CO (1) | CO2019009413A2 (fr) |
IL (1) | IL268929A (fr) |
MX (1) | MX2019010370A (fr) |
PE (1) | PE20200383A1 (fr) |
WO (1) | WO2018160827A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10737198B2 (en) | 2018-01-23 | 2020-08-11 | High Sierra Technologies, Inc. | Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons |
IL266151A (en) * | 2019-04-18 | 2019-07-31 | Kanabo Res Ltd | Dilute for the cannabinoid preparations |
WO2021012044A1 (fr) | 2019-07-22 | 2021-01-28 | Canopy Growth Corporation | Cristallisation continue de cannabinoïdes dans un réacteur à cuve agitée |
KR20220106158A (ko) * | 2019-11-26 | 2022-07-28 | 라이코드 리미티드 | 칸나비노이드 및 라이코펜 항염증 상승작용적 조합물 |
EP4142929A4 (fr) * | 2020-04-29 | 2024-02-21 | Ligar Lp | Polymères à empreinte et procédés pour leur utilisation |
CA3152633A1 (fr) * | 2020-07-27 | 2022-02-03 | Canopy Growth Corporation | Procedes de synthese de cannabielsoin et d'analogues de ceux-ci |
WO2022165165A1 (fr) * | 2021-01-29 | 2022-08-04 | The Johns Hopkins University | Effets de limonène sur l'anxiété induite par tétrahydrocannabinol (thc) |
CN113368086B (zh) * | 2021-08-11 | 2021-12-03 | 龙麻(上海)医药研发有限责任公司 | 一种大麻素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用 |
WO2023245185A1 (fr) * | 2022-06-17 | 2023-12-21 | New Growth Brands, Inc. | Compositions comprenant des cannabinoïdes et leurs procédés de préparation et d'utilisation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009019322A1 (de) * | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
TWI583374B (zh) * | 2010-03-30 | 2017-05-21 | Gw伐瑪有限公司 | 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途 |
CA2931039C (fr) * | 2013-11-20 | 2022-07-12 | Mary Lynch | Compositions et methodes de traitement de l'inflammation oculaire et de la douleur |
BR112017018316A2 (pt) * | 2015-02-27 | 2018-04-17 | Ebbu Llc | composições compreendendo combinações de canabinoides purificados, com pelo menos um flavonoide, terpeno ou mineral |
-
2018
- 2018-03-01 CN CN201880028815.7A patent/CN110582206A/zh active Pending
- 2018-03-01 EP EP18760302.2A patent/EP3589129A4/fr not_active Withdrawn
- 2018-03-01 BR BR112019018088-5A patent/BR112019018088A2/pt not_active Application Discontinuation
- 2018-03-01 AU AU2018227544A patent/AU2018227544A1/en not_active Abandoned
- 2018-03-01 PE PE2019001790A patent/PE20200383A1/es unknown
- 2018-03-01 MX MX2019010370A patent/MX2019010370A/es unknown
- 2018-03-01 CA CA3054690A patent/CA3054690A1/fr active Pending
- 2018-03-01 WO PCT/US2018/020440 patent/WO2018160827A1/fr unknown
-
2019
- 2019-08-26 IL IL26892919A patent/IL268929A/en unknown
- 2019-08-29 CO CONC2019/0009413A patent/CO2019009413A2/es unknown
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
IL268929A (en) | 2019-10-31 |
MX2019010370A (es) | 2019-10-22 |
AU2018227544A1 (en) | 2019-08-29 |
CN110582206A (zh) | 2019-12-17 |
CA3054690A1 (fr) | 2018-09-07 |
WO2018160827A1 (fr) | 2018-09-07 |
BR112019018088A2 (pt) | 2020-03-24 |
CO2019009413A2 (es) | 2019-09-09 |
PE20200383A1 (es) | 2020-02-24 |
EP3589129A1 (fr) | 2020-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3589129A4 (fr) | Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés | |
EP3478308A4 (fr) | Composition à base de cannabis et procédés | |
EP3471745A4 (fr) | Procédés et compositions pour réduire le stress oxydatif | |
EP3419676A4 (fr) | Compositions antimicrobiennes et leurs utilisations | |
EP3634390A4 (fr) | Compositions antimicrobiennes comprenant des cannabinoïdes et leurs méthodes d'utilisation | |
IL254025B (en) | Compositions containing a mixture of pure cannabinoids with at least one flavonoid, terpene or mineral | |
EP3380096A4 (fr) | Compositions d'huile de cannabis et leurs procédés de préparation | |
EP3313394A4 (fr) | Compositions antimicrobiennes contenant des cannabinoïdes | |
EP3352774A4 (fr) | Compositions de flavonoïdes et procédés d'utilisation | |
EP3600325A4 (fr) | Nouvelles compositions et méthodes | |
EP3569671A4 (fr) | Dérivé de méthylmenthol et composition conférant une sensation de fraîcheur en contenant | |
EP3496823A4 (fr) | Compositions ignifuges et leurs utilisations | |
EP3630962A4 (fr) | Variants de l'endonucléase cblb , compositions et procédés d'utilisation | |
EP3494119A4 (fr) | Composés et compositions, et utilisations associées | |
EP3487482A4 (fr) | Nouvelles formules de comprimés de cannabis. | |
EP3790861A4 (fr) | Compositions sénolytiques et utilisations associées | |
EP3630150A4 (fr) | Compositions anthelminthiques purifiées et méthodes associées | |
EP3801505A4 (fr) | Cannabinoïdes et leurs utilisations | |
EP3711782A4 (fr) | Composition hydrocolloïde et biopatch la comprenant | |
EP3897615A4 (fr) | Compositions de cannabis et méthodes | |
EP3310783A4 (fr) | Procédés et compositions de prévention et de traitement de la perte d'audition | |
EP3705127A4 (fr) | Composition contenant un extrait desalvia miltiorrhiza | |
EP3968974A4 (fr) | Cannabinoïdes et utilisations associées | |
EP3790923A4 (fr) | Polysiloxane modifié par blocs et compositions formées à partir de celui-ci | |
EP3687628A4 (fr) | Compositions et méthodes pour inhiber acss2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190807 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: MARTIN, JONATHAN REED Inventor name: REID, BRIAN GEOFFREY Inventor name: COOPER, JONATHAN MICHAEL Inventor name: LEVY, KURT |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20201022 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/352 20060101ALI20201016BHEP Ipc: A01N 65/00 20090101AFI20201016BHEP Ipc: A61K 31/05 20060101ALI20201016BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20210521 |